Diagnosis and Management of Low IgM Levels

Evaluation and Diagnosis

The initial priority is to distinguish between primary and secondary hypogammaglobulinemia by measuring total proteins and serum albumin, according to the American College of Allergy, Asthma, and Immunology 1
If total proteins and albumin are low along with decreased IgM, this strongly suggests secondary hypogammaglobulinemia due to protein loss (nephrotic syndrome, protein-losing enteropathy, or lymphatic disorders), as recommended by the American College of Allergy, Asthma, and Immunology 1
If total proteins and albumin are normal with low IgM, consider primary immunodeficiency, as only immunoglobulin production is affected, according to the American College of Allergy, Asthma, and Immunology 1

Enumeration of B cells by flow cytometry should be performed to distinguish between Common Variable Immunodeficiency (CVID) and agammaglobulinemia, as recommended by the American College of Allergy, Asthma, and Immunology 1
Specific antibody response tests to protein and polysaccharide antigens should be conducted, as they are more predictive of infection risk than immunoglobulin levels alone, according to the American College of Allergy, Asthma, and Immunology 1, 7

Patients with IgG <300 mg/dL have a high risk of severe bacterial infections and require urgent immunoglobulin replacement therapy, as recommended by the American College of Allergy, Asthma, and Immunology 1
Intravenous immunoglobulin (IGIV) should be administered at 0.2-0.4 g/kg body weight every 3-4 weeks, according to the American College of Allergy, Asthma, and Immunology 1
Subcutaneous immunoglobulin (IGSC) may provide more stable levels with fewer systemic effects, as recommended by the American College of Allergy, Asthma, and Immunology 1

Acute infections should be treated with aggressive antimicrobial therapy using longer courses than in immunocompetent patients, as recommended by the American College of Allergy, Asthma, and Immunology 7
Consider prophylactic antibiotics (trimethoprim-sulfamethoxazole) for patients with recurrent infections that negatively impact quality of life, according to the American College of Allergy, Asthma, and Immunology 7

Patients with very low or absent IgA may develop anti-IgA antibodies, creating a risk of anaphylactic reactions to blood products, as warned by the American College of Allergy, Asthma, and Immunology 1, 7
IgA-deficient blood products should be used when available for transfusions, as recommended by the American College of Allergy, Asthma, and Immunology 7

Immune function should be reevaluated regularly, especially in partial IgM deficiency that may progress, as recommended by the American College of Allergy, Asthma, and Immunology 7
Monitor for complications associated with CVID (autoimmune cytopenias, granulomatous disease) if CVID is confirmed, according to the American College of Allergy, Asthma, and Immunology 1
Fragility assessment should be considered in older adults before treatment, as recommended by the National Comprehensive Cancer Network 8